Seno’s management team has extensive experience in the commercialization of medical device products. The team has been selected based upon their experience in development and expertise to understand the regulatory hurdles involved in commercializing such products.
Janet Campbell Chief Executive Officer
Janet Campbell, Chief Executive Officer, is a co-founder of Seno Medical Instruments, Inc. Previously she served as President and Chief Operating Officer of InforMedix, Inc. Ms. Campbell is a successful entrepreneur in the medical device area. She held the position of Chief Executive Officer of Mach Diagnostics, a venture backed medical company focused on rapid diagnostics, where she raised two rounds of capital, and developed an organization that included 40 sales representatives and a nationwide distributor network. She was the founder and President of Health Tech, Inc., a cardiovascular technology company, where she negotiated multi-million dollar licensing and joint venture agreements involving Fortune 500 and early-stage bioscience companies.
Ms. Campbell was the health care partner of Rockecharlie & Co., a Houston investment-banking firm. She has extensive venture capital experience, having been key consultant to a variety of venture capital funds including the Woodlands Venture Fund (now the Woodlands/Essex Fund), Vanguard Ventures, and the Susquehanna Group. Ms. Campbell was Chairman of the Board of Directors of Vascular Genetics, Inc., representing Human Genome Sciences. Ms. Campbell received her BA from the University of Missouri, and was honored as alumni of the year in 2005. She received her MBA in finance from The Johns Hopkins University.
Thomas G. Miller, President - Tom has over 23 years of medical product experience including design, development, manufacturing, and FDA regulatory compliance. Before joining Seno, Tom was Executive Vice President of Fairway Medical Technologies (formally KVM Technologies) where he worked with Seno’s Chief Scientific Officer and the father of medical opto-acoustics Dr. Alexander Oraevsky.
In his duties as Vice President of KVM Technologies, Tom was involved in developing over 75 medical products in market areas encompassing cardiovascular, immunology, microbiology, hematology, rehabilitation, and drug-abuse, as well as providing specialty consulting services. Earlier in his career, Tom managed the Houston Area Service Operations for Motorola Communications and Electronics. Tom earned his Bachelor of Science degree in Chemistry at Roanoke College, and received extensive electronics and mechanical engineering training with the U.S. Navy Nuclear Propulsion Program
A. Thomas Stavros, MD, FACR, FSRU, FRANZCR. Dr. Stavros is a women’s imaging radiologist. Dr. Stavros’s main interests are general ultrasound, breast imaging and intervention, and ultrasound guided FNA and/or core biopsy in the thyroid and head and neck.
Dr. Stavros has been involved in mammography since 1976 and has been actively involved in the development of high-frequency, hand-held breast ultrasound since 1981. He has written or co-authored numerous articles, and he has also written the textbook Breast Ultrasound. He speaks extensively about ultrasound, particularly about breast ultrasound and has presented more than 1000 invited lectures and abstracts.
Dr. Stavros is a fellow of the American College of Radiology, a fellow of the Society of Radiologist in Ultrasound, and an honorary fellow of the Royal Australian and New Zealand College of Radiology, where he was the Traveling Baker Professor in 1999.
Barbara Lind, Vice President Corporate Development, has more than 20 years experience in strategic sales, marketing and new business development. She has developed strategies for new products and services, established sales relationships at the highest levels of corporations, and successfully worked with professional networks and focus groups to develop research agendas and launch new products. Lind oversees all Business Development and Marketing and Sales activities for Seno. She recently completed the first survey/focus group for the research instrument.
Prior to joining Seno, she was President of the Hawthorne Group, a strategic consultancy working with organizations confronting significant growth or change, particularly in relation to sales, marketing and new business development. Ms. Lind was one of the founding management of Renaissance Strategy Group, which was taken pulic on NASDAQ. Lind an industrial psychologist, holds a BA from Drake University in Des Moines, Iowa, and an MA from the University of Massachusetts, Amherst, where she also undertook her doctoral studies.
Don Herzog, Director of Engineering, has extensive project management skills and expertise in diagnostic ultrasound, medical information systems, image management, recording, image processing, image printers, laser systems and electro-optics. He recently led the development of the first real-time, 4D Doppler-based diagnostic system for vascular application. This technology has been acquired by a West Coast company, where it is being used to develop a method for the non-invasive measurement of intracranial pressure. This company is a multi-billion dollar medical device company.
Herzog was the individual at RCA responsible for inventing the optical recording and laser diodes as used in today’s CD’s and DVD’s, which was one of RCA’s most profitable patents. Herzog holds a B.S.E.E./M.S.E.E. in communications/controls from Drexel University, Philadelphia, PA.